Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Rawla, Prashanth, Sunkara, Tagore, Gaduputi, Vinaya·2019·World Journal of Oncology

Cited by (1,002)

Items 301–400 of 1,002

  1. Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers
    Giulia Mantini, Andrea Vallés‐Martí, Tessa Y. S. Le Large, Mjriam Capula, Niccola Funel, Thang V. Pham, Sander R. Piersma, Geert Kazemier M, Maarten F. Bijlsma, Elisa Giovannetti et al. · 2020 · Cellular Oncology
  2. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview
    Kanan Panchal, Rakesh Kumar Sahoo, Umesh Dutta Gupta, Akash Chaurasiya · 2021 · International Immunopharmacology
  3. Integrated lipidomics and proteomics reveal cardiolipin alterations, upregulation of HADHA and long chain fatty acids in pancreatic cancer stem cells
    Claudia Di Carlo, Bebiana C. Sousa, Marcello Manfredi, Jessica Brandi, Elisa Dalla Pozza, Emílio Marengo, Marta Palmieri, Ilaria Dando, Michael J.O. Wakelam, Andrea F. Lopez‐Clavijo et al. · 2021 · Scientific Reports
  4. Association of Diabetes Mellitus and Alcohol Abuse with Cancer: Molecular Mechanisms and Clinical Significance
    Bao Lam, Rashmi Srivastava, Jason Morvant, Sharmila Shankar, Rakesh K. Srivastava · 2021 · Cells
  5. Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
    Wei Liu, Mohamad‐Gabriel Alameh, June F. Yang, Jonathan R. Xu, Paulo J.C. Lin, Ying K. Tam, Drew Weissman, Jianxin You · 2022 · International Journal of Molecular Sciences
  6. The potential role of chitosan‐based nanoparticles as drug delivery systems in pancreatic cancer
    Fatemeh Sadoughi, Mohammad Alì Mansournia, Seyyed Mehdi Mirhashemi · 2020 · IUBMB Life
  7. Physical plasma-derived oxidants sensitize pancreatic cancer cells to ferroptotic cell death
    Naresh Kumar, Claudina Angela Perez-Novo, Priyanka Shaw, Emilie Logie, Angela Privat‐Maldonado, Sylvia Dewilde, Evelien Smits, Wim Vanden Berghe, Annemie Bogaerts · 2021 · Free Radical Biology and Medicine
  8. A 3D pancreatic tumor model to study T cell infiltration
    Mollica, Hilaria, Teo, Yi Juan, Tan, Alrina Shin Min, Tan, Damien Zhi Ming, Decuzzi, Paolo, Pavesi, Andrea, Adriani, Giulia · 2021 · Biomaterials Science
  9. COL11A1-Driven Epithelial–Mesenchymal Transition and Stemness of Pancreatic Cancer Cells Induce Cell Migration and Invasion by Modulating the AKT/GSK-3β/Snail Pathway
    Hui Wang, Huichao Zhou, Hong Ni, Xiaohong Shen · 2022 · Biomolecules
  10. Recognition of cancer mediating biomarkers using rough approximations enabled intuitionistic fuzzy soft sets based similarity measure
    Swarup Kr Ghosh, Anupam Ghosh, Siddhartha Bhattacharyya · 2022 · Applied Soft Computing
  11. A G-quadruplex-binding compound shows potent activity in human gemcitabine-resistant pancreatic cancer cells
    Ahmed A. Ahmed, Chiara Marchetti, Stephan A. Ohnmacht, Stephen Neidle · 2020 · Scientific Reports
  12. CD36 and CD97 in Pancreatic Cancer versus Other Malignancies
    Cristiana Tănase, Ancuța-Augustina Gheorghișan-Gălățeanu, Ionela Daniela Popescu, Simona Mihai, Elena Codrici, Radu Albulescu, Mihail Eugen Hinescu · 2020 · International Journal of Molecular Sciences
  13. Whipple Procedure: A Five-Year Clinical Experience in Tertiary Care Center
    Shabbar Hussain Changazi, Qamar A Ahmed, Samiullah Bhatti, Sumera Siddique, Eusha Abdul Raffay, Muhammad Waris Farooka, Mahmood Ayyaz · 2020 · Cureus
  14. Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
    Gustavo A. Arias-Pinilla, Helmout Modjtahedi · 2021 · Cancers
  15. Ziziphus nummularia Attenuates the Malignant Phenotype of Human Pancreatic Cancer Cells: Role of ROS
    Joelle Edward Mesmar, Manal Fardoun, Rola Abdallah, Yusra Al Dhaheri, Hadi Mohamad Yassine, Rabah Iratni, Adnan Badran, Ali Hussein Eid, Elias Baydoun · 2021 · Molecules
  16. Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective
    Concetta Panebianco, Davide Ciardiello, Annacandida Villani, Brigida Anna Maiorano, Tiziana Pia Latiano, Evaristo Maiello, Francesco Perri, Valerio Pazienza · 2021 · Seminars in Cancer Biology
  17. Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS
    Thaninee Prasoppokakorn, Thodsawit Tiyarattanachai, Roongruedee Chaiteerakij, Pakanat Decharatanachart, Parit Mekaroonkamol, Wiriyaporn Ridtitid, Pradermchai Kongkam, Rungsun Rerknimitr · 2021 · Endoscopic Ultrasound
  18. Modeling the mechanical stiffness of pancreatic ductal adenocarcinoma
    Delanyo Kpeglo, Matt D. G. Hughes, Lorna Dougan, Malcolm Haddrick, Margaret A. Knowles, Stephen D. Evans, Sally A. Peyman · 2022 · Matrix Biology Plus
  19. Trends and patterns in cancer nanotechnology research: A survey of NCI's caNanoLab and nanotechnology characterization laboratory
    Weina Ke, Rachael M. Crist, Jeffrey D. Clogston, Stęphan T. Stern, Marina A. Dobrovolskaia, Piotr A. Grodzinski, Mark A. Jensen · 2022 · Advanced Drug Delivery Reviews
  20. IL-15 armoring enhances the antitumor efficacy of claudin 18.2-targeting CAR-T cells in syngeneic mouse tumor models
    Hongtai Shi, Andi Li, Zhenyu Dai, Xue Jiao, Qi Zhao, Jiyuan Tian, Dandan Song, Hao Wang, Jianan Chen, Xiaokang Zhang et al. · 2023 · Frontiers in Immunology
  21. Fatty Pancreas Is a Risk Factor for Pancreatic Cancer: A Systematic Review and Meta-Analysis of 2956 Patients
    Mónika Lipp, Dorottya Tarján, Jimin Lee, Ádám Zolcsák, Eszter Ágnes Szalai, Brigitta Teutsch, Nándor Faluhelyi, Bálint Mihály Erőss, Péter Hegyi, Alexandra Mikó · 2023 · Cancers
  22. SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma
    Fei, Naomi, Wen, Sijin, Ramanathan, Rajesh, Hogg, Melissa E., Zureikat, Amer H., Lotze, Michael T., Bahary, Nathan, Singhi, Aatur D., Zeh, Herbert J., Boone, Brian A. · 2021 · Clinical and Translational Science
  23. Does pendimethalin develop in pancreatic cancer induced inflammation?
    Merve Arici, Mahmoud Abudayyak, Tuğçe Boran, Gül Özhan · 2020 · Chemosphere
  24. Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine
    Gregorio Di Franco, Alice Usai, Niccola Funel, Matteo Palmeri, Ida Elena Rosamaria Montesanti, Matteo Bianchini, Desirée Gianardi, Niccolò Furbetta, Simone Guadagni, Enrico Vasile et al. · 2020 · World Journal of Gastroenterology
  25. Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma
    Takuro Yamaguchi, Kenichiro Uemura, Yoshiaki Murakami, Naru Kondo, Naoya Nakagawa, Kenjiro Okada, Shingo Seo, Eiso Hiyama, Shin’ya Takahashi, Taijiro Sueda · 2020 · Annals of Surgical Oncology
  26. Catechol enhances chemo‑ and radio‑sensitivity by targeting AMPK/Hippo signaling in pancreatic cancer cells
    Jeong Moon, Meran Keshawa Ediriweera, Ji Ryu, Hee Jung Kim, Somi Kim Cho · 2021 · Oncology Reports
  27. Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy
    Verena Hofschröer, Karolina Najder, Micol Rugi, Rayhana Bouazzi, Marco Cozzolino, Annarosa Arcangeli, György Panyi, Albrecht Schwab · 2021 · Frontiers in Pharmacology
  28. Exosomes as Pleiotropic Players in Pancreatic Cancer
    Laura De Lellis, Rosalba Florio, Maria Cristina Di Bella, Davide Brocco, Francesca Guidotti, Nicola Tinari, Antonino Grassadonia, Rossano Lattanzio, Alessandro Cama, Serena Veschi · 2021 · Biomedicines
  29. 3d tissue models as tools for radiotherapy screening for pancreatic cancer
    Gabrielle Wishart, Priyanka Gupta, Giuseppe Schettino, A. Nisbet, Eirini G. Velliou · 2021 · British Journal of Radiology
  30. Role of Nrf2 in Pancreatic Cancer
    Marta Cykowiak, Violetta Krajka‐Kuźniak · 2021 · Antioxidants
  31. Piceatannol induces apoptotic cell death through activation of caspase-dependent pathway and upregulation of ROS-mediated mitochondrial dysfunction in pancreatic cancer cells
    İlknur Çınar Ayan, Ebru Güçlü, Hasibe Cıngıllı Vural, Hatice Gül Dursun · 2022 · Molecular Biology Reports
  32. Treatment Costs and Social Burden of Pancreatic Cancer
    Elżbieta Cipora, Olga Partyka, Monika Pajewska, Aleksandra Izabela Czerw, Katarzyna Sygit, Marian Sygit, Mateusz Kaczmarski, Dominika Mękal, Edyta Krzych‐Fałta, Anna Jurczak et al. · 2023 · Cancers
  33. Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma
    Thomas Kryza, Tashbib Khan, Simon G. Puttick, Chao Li, Kamil A. Sokolowski, Brian Wan-Chi Tse, Tahleesa Cuda, Nicholas Lyons, Madeline Gough, Julia X. M. Yin et al. · 2020 · Theranostics
  34. A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE)
    Iris W.J.M. van Goor, Lois A. Daamen, Marc G. Besselink, Anna M E Bruynzeel, Olivier R. Busch, Geert A. Cirkel, Bas Groot Koerkamp, Nadia Haj Mohammad, Hanne D. Heerkens, Hanneke W.M. van Laarhoven et al. · 2022 · Trials
  35. MicroRNA electrochemical biosensors for pancreatic cancer
    Fereshteh Rahdan, Fateme Bina, Elham Norouz Dolatabadi, Donya Shaterabadi, Seyyed Hossein Khatami, Yousof Karami, Nafiseh Dorosti, Mortaza Taheri‐Anganeh, Peyman Asadi, Rahmatollah Soltani et al. · 2023 · Clinica Chimica Acta
  36. Targeted Cyclo[8]pyrrole-Based NIR-II Photoacoustic Tomography Probe for Suppression of Orthotopic Pancreatic Tumor Growth and Intra-abdominal Metastases
    Jingqin Chen, Rui Chen, Calvin V. Chau, Adam C. Sedgwick, Qiang Xue, Tao Chen, Silüe Zeng, Ningbo Chen, Kenneth K. Y. Wong, Liang Song et al. · 2024 · Journal of the American Chemical Society
  37. Sirtuins as Key Regulators in Pancreatic Cancer: Insights into Signaling Mechanisms and Therapeutic Implications
    Surbhi Chouhan, Anil Kumar, Naoshad Muhammad, Darksha Usmani, Tabish Hasan Khan · 2024 · Cancers
  38. MEDICAL IMAGING FOR EARLY CANCER DIAGNOSIS AND EPIDEMIOLOGY USING ARTIFICIAL INTELLIGENCE: STRENGTHING NATIONAL HEALTHCARE FRAMEWORKS IN THE USA
    Md Ashraful Alam, Amir Sohel, Amjad Hossain, Sanjida Alam Eshra, Shaiful Mahmud, Washington, DC 20019, USA. · 2023 · American Journal of Scholarly Research and Innovation
  39. Fibronectin acts as a molecular switch to determine SPARC function in pancreatic cancer
    Amanda Munasinghe, Khalisha Malik, F Mohamedi-Yousufi, Stan Moaraf, Hemant Mahendrakumar Kocher, Lucy A. Jones, Natasha J. Hill · 2020 · Cancer Letters
  40. Polypyridyl‐Based Copper Phenanthrene Complexes: Combining Stability with Enhanced DNA Recognition
    Nicolò Zuin Fantoni, Zara E. Molphy, Sinéad O’Carroll, Georgia Menounou, George Mitrikas, Marios G. Krokidis, Chryssostomos Chatgilialoglu, John J. Colleran, Anna Banasiak, MARTIN M. CLYNES et al. · 2020 · Chemistry - A European Journal
  41. Clinical and Pre-Clinical Evidence of Carbonic Anhydrase IX in Pancreatic Cancer and Its High Expression in Pre-Cancerous Lesions
    Sabina Strapcova, Martina Takáčová, Lucia Csáderová, Paola Martinelli, Ľubomíra Lukáčiková, Viliam Gál, Juraj Kopáček, Eliška Švastová · 2020 · Cancers
  42. Expression Profile of GINS Complex Predicts the Prognosis of Pancreatic Cancer Patients
    Fanqin Bu, Xiaojian Zhu, Xuan Yi, Chen Huan Luo, Lin Kang, Jinfeng Zhu, Cegui Hu, Zitao Liu, Jiefeng Zhao, Chao Huang et al. · 2020 · OncoTargets and Therapy
  43. Microbiome and pancreatic ductal adenocarcinoma
    Annemilaï Tijeras‐Raballand, Marc Hilmi, Lucile Astorgues‐Xerri, Rémy Nicolle, Ivan Bièche, Cindy Neuzillet · 2021 · Clinics and Research in Hepatology and Gastroenterology
  44. Exploiting unique features of the gut-brain interface to combat gastrointestinal cancer
    Alyssa Schledwitz, Guofeng Xie, Jean‐Pierre Raufman · 2021 · Journal of Clinical Investigation
  45. Single‐Molecule Bioelectronic Label‐Free Assay of both Protein and Genomic Markers of Pancreatic Mucinous Cysts’ in Whole Blood Serum
    Eleonora Macchia, Lucia Sarcina, Caroline Driescher, Zahra Gounani, Amit Tewari, Ronald Österbacka, Gerardo Palazzo, Angelo Tricase, Zsolt Miklos Kovacs-Vajna, Fabrizio Antonio Viola et al. · 2021 · Advanced Electronic Materials
  46. A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma
    Eri Munekage, Satoshi Serada, Shigehiro Tsujii, Keiichiro Yokota, Keita Kiuchi, Kenji Tominaga, Minoru Fujimoto, Mizuki Kanda, Sunao Uemura, Tsutomu Namikawa et al. · 2021 · Neoplasia
  47. Integrated Systems Analysis of the Murine and Human Pancreatic Cancer Glycomes Reveals a Tumor-Promoting Role for ST6GAL1
    Emma Kurz, Shuhui Chen, Emily Vucic, Gillian G. Baptiste, Cynthia A. Loomis, Praveen Kumar Agrawal, Cristina H Hajdu, Dafna Bar‐Sagi, Lara K. Mahal · 2021 · Molecular & Cellular Proteomics
  48. Trends and Projections in National United States Health Care Spending for Gastrointestinal Malignancies (1996–2030)
    Igor Stukalin, Newaz Shubidito Ahmed, Adam Michael Fundytus, Alexander S. Qian, Stephanie B. Coward, Gilaad G. Kaplan, Robert J. Hilsden, Kelly W. Burak, Jeffrey K. Lee, Siddharth Singh et al. · 2021 · Gastroenterology
  49. The Emerging Role of PIWI-Interacting RNAs (piRNAs) in Gastrointestinal Cancers: An Updated Perspective
    Ismael Riquelme, Pablo Ernesto Pérez, Pablo J. Letelier, Priscilla Brebi, Juan Carlos Roa · 2021 · Cancers
  50. Aberrant expression of a novel circular RNA in pancreatic cancer
    Takahiro Seimiya, Motoyuki Otsuka, Takuma Iwata, Eri Tanaka, Kazuma Sekiba, Chikako Shibata, Masaru Moriyama, Ryo Nakagawa, Reo Maruyama, Kazuhiko Koike · 2020 · Journal of Human Genetics
  51. Global Trend in Pancreatic Cancer Prevalence Rates Through 2040: An Illness‐Death Modeling Study
    Zeinab Hesami, Meysam Olfatifar, Amir Sadeghi, Mohammad Reza Zali, Samira Mohammadi‐Yeganeh, Mohammad Amin Habibi, Mohammad Reza Ghadir, Hamidreza Houri · 2024 · Cancer Medicine
  52. The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltration
    Chiara Cencioni, Silvia Malatesta, Virginia Vigiano Benedetti, Valerio Licursi, Livia Perfetto, Federica Conte, Danilo Ranieri, Armando Bartolazzi, Martina Kunkl, Loretta Tuosto et al. · 2025 · Journal of Experimental & Clinical Cancer Research
  53. Difference in Long-Term Trends in COPD Mortality between China and the U.S., 1992–2017: An Age–Period–Cohort Analysis
    Haoyu Wen, Cong Hua Xie, Lu Wang, Fang Wang, Yafeng Wang, Xiaoxue Liu, Chuanhua Yu · 2019 · International Journal of Environmental Research and Public Health
  54. Application of liquid biopsy for surgical management of pancreatic cancer
    Minako Nagai, Masayuki Sho, Takahiro Akahori, Kenji Nakagawa, Kota Nakamura · 2020 · Annals of Gastroenterological Surgery
  55. GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets
    Krishna Sriram, Cristina Salmerón, Shu Z. Wiley, Paul A. Insel · 2020 · British Journal of Pharmacology
  56. Evaluation of the In Vitro Cytotoxic Activity of Caffeic Acid Derivatives and Liposomal Formulation against Pancreatic Cancer Cell Lines
    Magdalena Zaremba-Czogalla, Anna Jaromin, Katarzyna Sidoryk, Agnieszka Zagórska, Marcin Cybulski, Jerzy Gubernator · 2020 · Materials
  57. DLX6-AS1: a putative lncRNA candidate in multiple human cancers
    Mohsen Sheykhhasan, Yaghoub Ahmadyousefi, Reihaneh Seyedebrahimi, Hamid Tanzadehpanah, Hamed Manoochehri, Paola Dama, Nashmin Fayazi Hosseini, Mohammad Akbari, Mohsen Eslami Farsani · 2021 · Expert Reviews in Molecular Medicine
  58. The Therapeutic Potential of FLASH-RT for Pancreatic Cancer
    Chidi M. Okoro, Emil Schüler, Cullen M. Taniguchi · 2022 · Cancers
  59. Aberrant RNA Splicing Is a Primary Link between Genetic Variation and Pancreatic Cancer Risk
    Jianbo Tian, Can Chen, Meilin Rao, Ming Zhang, Zequn Lu, Yimin Cai, Pingting Ying, Bin Li, Haoxue Wang, Lu Wang et al. · 2022 · Cancer Research
  60. Real-world study of surgical treatment of pancreatic cancer in China: annual report of China Pancreas Data Center (2016–2020)
    Wenming Wu, Yi Miao, Yinmo Yang, Wenhui Lou, Yupei Zhao · 2021 · Journal of Pancreatology
  61. Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction
    Da Eun Lee, Hyeon Woong Kang, So Yi Kim, Myeong‐Jin Kim, Jae Woong Jeong, Woosol Chris Hong, Sungsoon Fang, Hyung Sun Kim, Yun Sun Lee, Hyo Jung Kim et al. · 2022 · Frontiers in Pharmacology
  62. A systematic review and meta‐analysis of observational studies of the association between the use of incretin‐based therapies and the risk of pancreatic cancer
    Khemayanto Hidayat, Ying‐Yi Zhou, Hong‐Zhen Du, Li‐Qiang Qin, Bimin Shi, Zeng‐Ning Li · 2022 · Pharmacoepidemiology and Drug Safety
  63. Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches
    Milad Ashrafizadeh, Kuo Luo, Wei Zhang, Amir Reza Aref, Xianbin Zhang · 2023 · Environmental Research
  64. MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma
    Australian Pancreatic Cancer Genome Initiative (APGI), Lesley E. Castillo, Adelaide I.J. Young, Amanda Mawson, Pia Schafranek, Angela M. Steinmann, Danielle Nessem, Ashleigh Parkin, Amber L. Johns, Angela S. Y. Chou et al. · 2019 · Oncogene
  65. Development and validation of a novel 3-gene prognostic model for pancreatic adenocarcinoma based on ferroptosis-related genes
    Jihua Yang, Xiao‐Hong Wei, Fang Hu, Wei Dong, Liao Sun · 2022 · Cancer Cell International
  66. The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives
    Fotini Poyia, Christiana Michael Neophytou, Maria Christodoulou, Panagiotis Papageorgis · 2024 · International Journal of Molecular Sciences
  67. Mast cells: key players in digestive system tumors and their interactions with immune cells
    Feihong Shu, Jie Yu, Youjia Liu, Fang Wang, Guoyou Gou, Min Wen, Chen Luo, Xianmin Lu, Yanxia Hu, Qian Du et al. · 2025 · Cell Death Discovery
  68. The Membrane Protein Sortilin Can Be Targeted to Inhibit Pancreatic Cancer Cell Invasion
    Fangfang Gao, Nathan Griffin, Sam Faulkner, Xiang Li, Simon J. King, Phillip Jobling, Jim W. Denham, Chen Chen Jiang, Hubert Hondermarck · 2020 · American Journal Of Pathology
  69. A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer
    Masanori Oshi, Yoshihisa Tokumaru, Ankit P. Patel, Li Yan, Ryusei Matsuyama, Itaru Endo, Matthew H. G. Katz, Kazuaki Takabe · 2020 · Cancers
  70. Efficacy and safety of EUS biliary drainage in malignant distal and hilar biliary obstruction: A comprehensive review of literature and algorithm
    Pradermchai Kongkam, Stanley Khoo, NhanDuc Tri · 2020 · Endoscopic Ultrasound
  71. Combating pancreatic cancer chemoresistance by triggering multiple cell death pathways
    Patricia Santofimia‐Castaño, Juan Iovanna · 2021 · Pancreatology
  72. Chelidonine Induces Apoptosis via GADD45a-p53 Regulation in Human Pancreatic Cancer Cells
    Hyun‐Jin Jang, Jae‐Ho Yang, Eunmi Hong, Eunbi Jo, Soon Lee, Sanghun Lee, Jong Soon Choi, Hwa‐Seung Yoo, Hyuno Kang · 2021 · Integrative Cancer Therapies
  73. Identification of Fucosylated SERPINA1 as a Novel Plasma Marker for Pancreatic Cancer Using Lectin Affinity Capture Coupled with iTRAQ-Based Quantitative Glycoproteomics
    Chia‐Chun Wu, Yuting Lu, Ta‐Sen Yeh, Yun-Hsin Chan, Srinivas Dash, Jau‐Song Yu · 2021 · International Journal of Molecular Sciences
  74. FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression
    Jinfeng Zhu, Jiefeng Zhao, Chen Huan Luo, Jinfeng Zhu, Xingyu Peng, Xiaojian Zhu, Lin Kang, Fanqin Bu, Wenjun Zhang, Qing Li et al. · 2022 · Cell Death and Disease
  75. Emerging role of pancreatic stellate cell-derived extracellular vesicles in pancreatic cancer
    Rohit Sarkar, Zhihong Xu, Chamini Jayamali Perera, Minoti Vivek Apte · 2023 · Seminars in Cancer Biology
  76. Automatic Detection of Pancreatic Lesions and Main Pancreatic Duct Dilatation on Portal Venous CT Scans Using Deep Learning
    Clément Abi Nader, Rebeca Vétil, Laura Kate Wood, Marc-Michel Rohé, Alexandre Bône, Hedvig Karteszi, Marie‐Pierre Vullierme · 2023 · Investigative Radiology
  77. Challenges of Managing Type 3c Diabetes in the Context of Pancreatic Resection, Cancer and Trauma
    Colton D. Wayne, Chahrazed Benbetka, Gail Ellen Besner, Siddharth Narayanan · 2024 · Journal of Clinical Medicine
  78. Clinical usefulness of C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in patients undergoing surgical resection of pancreatic cancer
    SHINNOSUKE KAWAHARA, Toru Aoyama, Masaaki Murakawa, Rei Kanemoto, Naohiko Matsushita, ITARU HASHIMOTO, Mariko Kamiya, Yukio Maezawa, Satoshi Kobayashi, Makoto Ueno et al. · 2024 · Langenbeck s Archives of Surgery
  79. Functional expression of the transient receptor potential ankyrin type 1 channel in pancreatic adenocarcinoma cells
    Florentina Cojocaru, Tudor Şelescu, Dan T. Domocos, Luminita Gabriela Marutescu, Gabriela N. Chirițoiu, Nicoleta-Raluca Chelaru, Simona Dima, Dan Florin Mihailescu, Alexandru Babeș, Dana Cucu · 2021 · Scientific Reports
  80. Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration
    Laura E. Kane, Gregory S. Mellotte, Kevin C. Conlon, Barbara Mary Ryan, Stephen G. Maher · 2021 · Cancers
  81. Escin inhibits angiogenesis by suppressing interleukin‑8 and vascular endothelial growth factor production by blocking nuclear factor‑κB activation in pancreatic cancer cell lines
    Kan Omi, Yoichi Matsuo, Goro Ueda, Yoshinaga Aoyama, Tomokatsu Kato, Yuichi Hayashi, Hiroyuki Imafuji, Kenta Saito, Ken Tsuboi, Mamoru Morimoto et al. · 2021 · Oncology Reports
  82. CDKN2A-Mutated Pancreatic Ductal Organoids from Induced Pluripotent Stem Cells to Model a Cancer Predisposition Syndrome
    Jessica Merkle, Markus Breunig, Maximilian Schmid, Chantal Allgöwer, Jana Krüger, Michael Karl Melzer, Susanne Bens, Reiner Siebert, Lukas Perkhofer, Ninel Azoitei et al. · 2021 · Cancers
  83. Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment
    Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques, Laura Wisniewski, Emma Newport, Vinothini Rajeeve, Rebecca J.G. Drake, Jesús Gómez-Escudero, Frances M. Richards et al. · 2022 · Cancer Research
  84. Differentiation of pancreatic ductal adenocarcinoma and chronic pancreatitis using graph neural networks on histopathology and collagen fiber features
    Bin Li, Michael S. Nelson, Omid Savari, Agnes G. Loeffler, Kevin W. Eliceiri · 2022 · Journal of Pathology Informatics
  85. Surgical Treatment of Pancreatic Cancer: Currently Debated Topics on Vascular Resection
    Sergio Pedrazzoli · 2023 · Cancer Control
  86. Prospective assessment of pancreatic ductal adenocarcinoma diagnosis from endoscopic ultrasonography images with the assistance of deep learning
    Jionghui Gu, Jinhua Pan, Jiayu Hu, Lulu Dai, Ke Zhang, Baohua Wang, Mengna He, Qiyu Zhao, Tianan Jiang · 2023 · Cancer
  87. Screening and identification of potential biomarkers for pancreatic cancer: An integrated bioinformatics analysis
    Somayeh Jafari, Milad Ravan, Iman Karimi-Sani, Hamid Aria, Amin Moradi Hasan‐Abad, Bahar Banasaz, Amir Atapour, Gholamreza Anani Sarab · 2023 · Pathology - Research and Practice
  88. Biomarkers and biosensors for early cancer diagnosis, monitoring and prognosis
    Mugip Rahaman Abdul Wahab, Thirunavukkarasu Palaniyandi, Maddaly Ravi, Sandhiya Viswanathan, Gomathy Baskar, Hemapreethi Surendran, S.G.D. Gangadharan, Barani Kumar Rajendran · 2023 · Pathology - Research and Practice
  89. MicroRNA-4516 suppresses pancreatic cancer development via negatively regulating orthodenticle homeobox 1
    Shuo Chen, Meng Michelle Xu, Jing Zhao, Jiaqi Shen, Junhui Li, Yang Liu, Gang Cao, Jiancang Ma, Weizhou He, Xi Chen et al. · 2020 · International Journal of Biological Sciences
  90. Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels
    Panebianco, Concetta, Trivieri, Nadia, Villani, Annacandida, Terracciano, Fulvia, Latiano, Tiziana Pia, Potenza, Adele, Perri, Francesco, Binda, Elena, Pazienza, Valerio · 2021 · Biomolecules
  91. Deep learning for pancreas segmentation on computed tomography: a systematic review
    Andrea Moglia, Matteo Cavicchioli, Luca Tommaso Mainardi, Pietro Cerveri · 2025 · Artificial Intelligence Review
  92. New avenues in pancreatic cancer: exploiting microRNAs as predictive biomarkers and new approaches to target aberrant metabolism
    Mjriam Capula, Giulia Mantini, Niccola Funel, Elisa Giovannetti · 2019 · Expert Review of Clinical Pharmacology
  93. Cost-Effectiveness Analysis of Olaparib Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer
    Na Li, Huanrui Zheng, Yanlei Huang, Bin Zheng, Hongfu Cai, Maobai Liu · 2021 · Frontiers in Pharmacology
  94. Benzophenones from Betula alnoides with Antiausterity Activities against the PANC-1 Human Pancreatic Cancer Cell Line
    Ashraf M. Omar, Sijia Sun, Min Jo Kim, Nguyễn Duy Phan, Ahmed M. Tawila, Suresh Awale · 2021 · Journal of Natural Products
  95. Integrated Analysis of Microarray and RNA-Seq Data for the Identification of Hub Genes and Networks Involved in the Pancreatic Cancer
    Maryum Nisar, Rehan Zafar Paracha, Iqra Arshad, Sidra Adil, Sabaoon Zeb, Rumeza Hanif, Mehak Rafiq, Zamir Hussain · 2021 · Frontiers in Genetics
  96. Crosstalk between hypoxia-sensing ULK1/2 and YAP-driven glycolysis fuels pancreatic ductal adenocarcinoma development
    Yu Jia, Huiyan Li, Ying Wang, Jue Wang, Jingwen Zhu, Yanyan Wei, Lou Lu, Xing Chen, Shi‐Jing Mo · 2021 · International Journal of Biological Sciences
  97. Preoperative Nutrition Intervention in Patients Undergoing Resection for Upper Gastrointestinal Cancer: Results from the Multi-Centre NOURISH Point Prevalence Study
    Irene Deftereos, Justin M. C. Yeung, Janan Arslan, Vanessa M. Carter, Elisabeth A. Isenring, Nicole K. Kiss, on behalf of The Nourish Point Prevalence Study Group · 2021 · Nutrients
  98. Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer
    Tao Lu, Jai Prakash · 2021 · International Journal of Nanomedicine
  99. Herbals and Plants in the Treatment of Pancreatic Cancer: A Systematic Review of Experimental and Clinical Studies
    John K. Triantafillidis, Eleni Triantafyllidi, Michail Ch. Sideris, Theodoros Pittaras, Apostolos E. Papalois · 2022 · Nutrients
  100. The role of circular RNAs in pancreatic cancer: new players in tumorigenesis and potential biomarkers
    Arezou Sayad, Sajad Najafi, Bashdar Mahmud Hussen, Elena Jamali, Mohammad Naser Taheri, Soudeh Ghafouri‐Fard · 2022 · Pathology - Research and Practice